WHO extends agreement with Bayer
Donation of nifurtimox increased to fight Chagas disease
07 March 2011 | Geneva
The World Health Organization (WHO) has signed an extension of its agreement with the pharmaceutical company, Bayer as part of its strategy to control and eliminate Chagas disease.
Under the terms of the 5-year extension starting April 2012, Bayer will increase the donation of nifurtimox to WHO from its current 2.5 million tablets over 5 years to 5 million tablets until 2017. The company has also announced the continuation of its cash contribution to fund logistics and distribution.
The agreement was signed on 4 March 2012 in Berlin, Germany by Dr Hiroki Nakatani and Mr Andreas Fibig, President of Bayer HealthCare Pharmaceuticals.
